Literature DB >> 11964179

Expression and characterization of the active molecular forms of choline/ethanolamine kinase-alpha and -beta in mouse tissues, including carbon tetrachloride-induced liver.

Chieko Aoyama1, Akiko Ohtani, Kozo Ishidate.   

Abstract

Choline/ethanolamine kinase (ChoK/EtnK) exists as at least three isoforms (alpha1, alpha2 and beta) in mammalian cells. The physiological significance for the existence of more than one form of the enzyme, however, remains to be determined. In the present study, we examined the expression and distribution of the isoforms in mouse tissues using isoform-specific cDNA probes and polyclonal antibodies raised against each N-terminal peptide sequence. Both Northern- and Western-blot analyses indicated that either the alpha (alpha1 plus alpha2) or the beta isoform appeared to be the ubiquitously expressed enzyme. The mRNA abundance for the alpha isoform was highest in testis, whereas that for the beta isoform was relatively high in heart and liver. While the native form of each isoform was reported to consist of either homodimers or homotetramers, our immunotitration studies clearly indicated that a considerable part of the active form of the enzyme consists of alpha/beta hetero-oligomers, with relatively small parts of activity expressed by alpha/alpha and beta/beta homo-oligomers. This is the first experimental evidence for the presence of heteromeric ChoK/EtnK in any source. Thus our results strongly suggested that the activity of ChoK/EtnK in the cell is controlled not only by the level of each isoform but also by their combination to form the active oligomer complex. Carbon tetrachloride (CCl(4)) was shown to induce ChoK activity 2-4-fold in murine liver. Our analysis for the mechanism involved in this induction revealed that the responsible isoform for CCl(4) was alpha, not beta. The level of alpha mRNA was strongly induced in mouse liver, which resulted in a sustained increase in the amount of the alpha isoform. Consequently, the composition of alpha/alpha homo-oligomers came to represent up to 80% of the total active molecular form of ChoK in CCl(4)-induced liver, whereas it was less than 20% in normal uninduced liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964179      PMCID: PMC1222531          DOI: 10.1042/0264-6021:3630777

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Choline/ethanolamine kinase from rat kidney.

Authors:  K Ishidate; Y Nakazawa
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

2.  Choline/ethanolamine kinase from rat liver.

Authors:  T J Porter; C Kent
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

3.  Reactive oxygen species in the progression of CCl4-induced liver injury.

Authors:  I G Sipes; A E el Sisi; W W Sim; S A Mobley; D L Earnest
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

4.  Purification and properties of choline kinase from rat brain.

Authors:  T Uchida; S Yamashita
Journal:  Biochim Biophys Acta       Date:  1990-04-17

5.  The involvement of Kupffer cells in carbon tetrachloride toxicity.

Authors:  M J Edwards; B J Keller; F C Kauffman; R G Thurman
Journal:  Toxicol Appl Pharmacol       Date:  1993-04       Impact factor: 4.219

6.  Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species.

Authors:  A E elSisi; D L Earnest; I G Sipes
Journal:  Toxicol Appl Pharmacol       Date:  1993-04       Impact factor: 4.219

7.  The Drosophila easily shocked gene: a mutation in a phospholipid synthetic pathway causes seizure, neuronal failure, and paralysis.

Authors:  P Pavlidis; M Ramaswami; M A Tanouye
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

8.  Regulation of choline kinase R: analyses of alternatively spliced choline kinases and the promoter region.

Authors:  T Uchida
Journal:  J Biochem       Date:  1994-09       Impact factor: 3.387

9.  Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation.

Authors:  J D Morrow; J A Awad; T Kato; K Takahashi; K F Badr; L J Roberts; R F Burk
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation.

Authors:  B Jiménez; L del Peso; S Montaner; P Esteve; J C Lacal
Journal:  J Cell Biochem       Date:  1995-01       Impact factor: 4.429

View more
  21 in total

1.  Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.

Authors:  Rutger J Dost; Andor W J M Glaudemans; Anthonius J Breeuwsma; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

2.  Phosphatidylcholine biosynthesis during neuronal differentiation and its role in cell fate determination.

Authors:  Hebe Marcucci; Luciana Paoletti; Suzanne Jackowski; Claudia Banchio
Journal:  J Biol Chem       Date:  2010-06-05       Impact factor: 5.157

3.  Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.

Authors:  Jacqueline V Chapman; Valérie Gouazé-Andersson; Maria C Messner; Margaret Flowers; Ramin Karimi; Mark Kester; Brian M Barth; Xin Liu; Yong-Yu Liu; Armando E Giuliano; Myles C Cabot
Journal:  Biochem Pharmacol       Date:  2010-04-10       Impact factor: 5.858

4.  New splicing mutation in the choline kinase beta (CHKB) gene causing a muscular dystrophy detected by whole-exome sequencing.

Authors:  Jorge Oliveira; Luís Negrão; Isabel Fineza; Ricardo Taipa; Manuel Melo-Pires; Ana Maria Fortuna; Ana Rita Gonçalves; Hugo Froufe; Conceição Egas; Rosário Santos; Mário Sousa
Journal:  J Hum Genet       Date:  2015-03-05       Impact factor: 3.172

Review 5.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

6.  A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis.

Authors:  Satomi Mitsuhashi; Aya Ohkuma; Beril Talim; Minako Karahashi; Tomoko Koumura; Chieko Aoyama; Mana Kurihara; Ros Quinlivan; Caroline Sewry; Hiroaki Mitsuhashi; Kanako Goto; Burcu Koksal; Gulsev Kale; Kazutaka Ikeda; Ryo Taguchi; Satoru Noguchi; Yukiko K Hayashi; Ikuya Nonaka; Roger B Sher; Hiroyuki Sugimoto; Yasuhito Nakagawa; Gregory A Cox; Haluk Topaloglu; Ichizo Nishino
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

Review 7.  Choline metabolism-based molecular diagnosis of cancer: an update.

Authors:  Kristine Glunde; Marie-France Penet; Lu Jiang; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Expert Rev Mol Diagn       Date:  2015-04-28       Impact factor: 5.225

8.  Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.

Authors:  Bum Soo Hong; Abdellah Allali-Hassani; Wolfram Tempel; Patrick J Finerty; Farrell Mackenzie; Svetoslav Dimov; Masoud Vedadi; Hee-Won Park
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

9.  Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis.

Authors:  Gengshu Wu; Chieko Aoyama; Stephen G Young; Dennis E Vance
Journal:  J Biol Chem       Date:  2007-11-19       Impact factor: 5.157

10.  Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.

Authors:  David Gallego-Ortega; Ana Ramirez de Molina; Maria Angeles Ramos; Fatima Valdes-Mora; Maria Gonzalez Barderas; Jacinto Sarmentero-Estrada; Juan Carlos Lacal
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.